Variant report

Variant	nsv523411
Chromosome Location	chr9:17394536-17454799
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BRCA1	chr9:17396862-17396940	H1-hESC	embryonic stem cell:	n/a	n/a
2	CEBPB	chr9:17397502-17397682	IMR90	lung:	n/a	n/a
3	CEBPB	chr9:17440917-17441132	HepG2	liver:	n/a	chr9:17441002-17441013
4	CEBPB	chr9:17437376-17437608	A549	lung:	n/a	chr9:17437440-17437453 chr9:17437442-17437451 chr9:17437442-17437451 chr9:17437440-17437453 chr9:17437442-17437453 chr9:17437442-17437451 chr9:17437442-17437453 chr9:17437440-17437453 chr9:17437442-17437451
5	CEBPB	chr9:17406793-17407054	IMR90	lung:	n/a	chr9:17406919-17406930 chr9:17406918-17406931
6	CEBPB	chr9:17419882-17420104	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr9:17398373-17398650	IMR90	lung:	n/a	n/a
8	CEBPB	chr9:17406868-17407046	HepG2	liver:	n/a	chr9:17406919-17406930 chr9:17406918-17406931
9	CEBPB	chr9:17398398-17398610	Hela-S3	cervix:	n/a	n/a
10	CEBPB	chr9:17406822-17407056	A549	lung:	n/a	chr9:17406919-17406930 chr9:17406918-17406931
11	CEBPB	chr9:17397451-17397769	H1-hESC	embryonic stem cell:	n/a	n/a
12	CEBPB	chr9:17440948-17441127	A549	lung:	n/a	chr9:17441002-17441013
13	CEBPB	chr9:17437391-17437559	H1-hESC	embryonic stem cell:	n/a	chr9:17437440-17437453 chr9:17437442-17437451 chr9:17437442-17437451 chr9:17437440-17437453 chr9:17437442-17437453 chr9:17437442-17437451 chr9:17437442-17437453 chr9:17437440-17437453 chr9:17437442-17437451
14	CEBPB	chr9:17440906-17441152	IMR90	lung:	n/a	chr9:17441002-17441013
15	CEBPB	chr9:17423031-17423372	IMR90	lung:	n/a	n/a
16	CHD1	chr9:17396955-17397053	H1-hESC	embryonic stem cell:	n/a	n/a
17	CTCF	chr9:17402420-17402570	SK-N-SH_RA	brain:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
18	CTCF	chr9:17402500-17402650	AoAF	blood vessel:	n/a	chr9:17402500-17402518
19	CTCF	chr9:17402447-17402553	Gliobla	brain:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
20	CTCF	chr9:17402340-17402490	NHLF	lung:	n/a	n/a
21	CTCF	chr9:17402444-17402584	HepG2	liver:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
22	CTCF	chr9:17402440-17402590	NB4	blood:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
23	CTCF	chr9:17402460-17402610	HMF	breast:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
24	CTCF	chr9:17402262-17402688	HCT-116	colon:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
25	CTCF	chr9:17402520-17402670	HAc	cerebellar:	n/a	n/a
26	CTCF	chr9:17402400-17402550	HRPEpiC	eye:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
27	CTCF	chr9:17402259-17402864	H1-hESC	embryonic stem cell:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
28	CTCF	chr9:17402460-17402610	AG04450	lung:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
29	CTCF	chr9:17402420-17402570	HVMF	connective:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
30	CTCF	chr9:17402480-17402630	HFF-Myc	foreskin:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
31	CTCF	chr9:17402580-17402730	HFF-Myc	foreskin:	n/a	n/a
32	CTCF	chr9:17402400-17402550	AG10803	skin:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
33	CTCF	chr9:17402440-17402590	Hela-S3	cervix:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
34	CTCF	chr9:17402420-17402570	HMEC	breast:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
35	CTCF	chr9:17402520-17402670	RPTEC	kidney:	n/a	n/a
36	CTCF	chr9:17402380-17402530	HEK293	kidney:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
37	CTCF	chr9:17402440-17402590	AG04449	skin:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
38	CTCF	chr9:17402460-17402610	AG04449	skin:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
39	CTCF	chr9:17402380-17402530	GM06990	blood:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
40	CTCF	chr9:17402420-17402570	BE2_C	brain:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
41	CTCF	chr9:17402440-17402640	GM12878	blood:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
42	CTCF	chr9:17402573-17402576	GM13977	blood:	n/a	n/a
43	CTCF	chr9:17402321-17402692	IMR90	lung:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
44	CTCF	chr9:17402780-17402930	NHLF	lung:	n/a	n/a
45	CTCF	chr9:17402400-17402550	HVMF	connective:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
46	CTCF	chr9:17402420-17402570	HBMEC	blood vessel:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
47	CTCF	chr9:17402760-17402910	HFF	foreskin:	n/a	n/a
48	CTCF	chr9:17402460-17402610	HPAF	blood vessel:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
49	CTCF	chr9:17402434-17402556	MCF-7	breast:	n/a	chr9:17402495-17402516 chr9:17402500-17402518
50	CTCF	chr9:17402420-17402570	HA-sp	spinal cord:	n/a	chr9:17402495-17402516 chr9:17402500-17402518

No.	Distal block	Cell Line	Cell type
1	chr9:17219155..17220052-chr9:17401883..17402825,5	MCF-7	breast:
2	chr9:17116081..17117141-chr9:17402172..17402905,3	MCF-7	breast:
3	chr9:17219375..17219930-chr9:17402045..17403347,3	MCF-7	breast:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-SH3GL2-1	chr9:17435732-17437445	NONHSAT130302
2	lnc-SH3GL2-2	chr9:17415816-17415879	NONHSAT130301
3	lnc-BNC2-4	chr9:17447143-17448541	NONHSAT130303
4	lnc-SH3GL2-2	chr9:17415964-17416187	NONHSAT130301
5	lnc-SH3GL2-2	chr9:17444195-17444244	NONHSAT130301

Variant related genes	Relation type
ENSG00000224488	TF binding region
CNTLN	TF binding region

Extended variants
information (count: 2636 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:2636 , 50 per page) page: 1 2 3 4 5 6 7 ... 53

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs7035276	chr9:17394536-17394537	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs542037250	chr9:17394549-17394550	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs181851213	chr9:17394550-17394551	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs369802393	chr9:17394551-17394552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs531244072	chr9:17394557-17394558	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs551838719	chr9:17394561-17394562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs372592353	chr9:17394575-17394576	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs570423982	chr9:17394602-17394603	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
9	rs528114805	chr9:17394632-17394633	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
10	rs16935601	chr9:17394648-17394649	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
11	rs547035147	chr9:17394664-17394665	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
12	rs369345129	chr9:17394676-17394677	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs200761681	chr9:17394682-17394683	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs371270152	chr9:17394701-17394702	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs374178844	chr9:17394784-17394785	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs200107103	chr9:17394785-17394786	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs377754640	chr9:17394794-17394795	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs146287840	chr9:17394798-17394799	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs138152539	chr9:17394802-17394803	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs539718673	chr9:17394805-17394806	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs367724376	chr9:17394849-17394850	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs149527170	chr9:17394850-17394851	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs61730197	chr9:17394852-17394853	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs369185770	chr9:17394853-17394854	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs367960018	chr9:17394871-17394872	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs73428107	chr9:17394873-17394874	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
27	rs553019050	chr9:17394877-17394878	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs565204572	chr9:17394886-17394887	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs375115420	chr9:17394906-17394907	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs369975567	chr9:17394908-17394909	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs372194162	chr9:17394924-17394925	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs114129881	chr9:17394930-17394931	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs369160472	chr9:17394933-17394934	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs201722678	chr9:17394946-17394947	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs201271465	chr9:17394947-17394948	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs202094174	chr9:17394950-17394951	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs200206318	chr9:17394973-17394974	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs575793749	chr9:17394983-17394984	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs373761923	chr9:17394992-17394993	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs144166918	chr9:17394994-17394995	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs3739489	chr9:17394996-17394997	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
42	rs201815103	chr9:17394997-17394998	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs201062003	chr9:17395011-17395012	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs376132105	chr9:17395017-17395018	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs201934878	chr9:17395041-17395042	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs200375718	chr9:17395047-17395048	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs115203335	chr9:17395078-17395079	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs370460738	chr9:17395080-17395081	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs569065967	chr9:17395105-17395106	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs3739488	chr9:17395108-17395109	Enhancers Weak transcription Flanking Active TSS Strong transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
abnormal development	18461090	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Breast cancer	16272173	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17133270	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Cervical cancer	21063398	CNVD
Retinoblastoma	22278416	CNVD
Splenic marginal zone lymphoma	18492102	CNVD
Melanoma	18172304	CNVD
Biliary cancer	19435499	CNVD
Gastric cancer	21586687	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myopathy	18421352	CNVD
Neuroblastoma	18664255	CNVD
Acute lymphoblastic leukemia	18957548	CNVD
Myeloproliferative neoplasm	17564968	CNVD
Malignant meningioma	17937814	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	17603634	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Oligodendroglial tumors	17285580	CNVD
Cutaneous squamous cell carcinomas	19131950	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Chordoma	18071362	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Renal cell carcinoma	18592004	CNVD
Developmental delay	19490664	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
microdeletion syndrome	16199537	CNVD
Non-syndromic sensorineural hearing loss	21987784	CNVD
Cancer	20164919	CNVD
Chronic myeloid leukemia	21384125	CNVD
Ovarian cancer	21720365	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Lung cancer	18438408	CNVD
Urothelial carcinoma	21177765	CNVD
Oral cancer	21386901	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21785460	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21858162	CNVD
Renal cell carcinoma	21668985	CNVD
Myelodysplastic syndrome	21251322	CNVD
Autism	22495311	CNVD
Hepatocellular carcinoma	18803288	CNVD
Metanephric adenoma	20802469	CNVD
Developmental delay	21147756	CNVD
Pilocytic astrocytoma	18670637	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Melanoma	22183965	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Myelofibrosis	22110671	CNVD
Glycine encephalopathy	21572526	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-small cell lung cancer	19010865	CNVD
Myoepithelioma	18604193	CNVD
Breast cancer	22522925	CNVD
Autism	20858261	CNVD
Epilepsy	20858261	CNVD
Mental retardation	20858261	CNVD
Breast cancer	21364760	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
early-passage human iPS cells	21368824	CNVD
Renal cell carcinoma	21215367	CNVD

Chromatin state (count:375 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr9:17362000-17394600	Weak transcription	iPS-20b Cell Line	embryonic stem cell
2	chr9:17368400-17394600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
3	chr9:17368400-17457800	Weak transcription	Pancreas	Pancrea
4	chr9:17368600-17394800	Weak transcription	Adipose Nuclei	Adipose
5	chr9:17368600-17411200	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
6	chr9:17368600-17411400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
7	chr9:17368600-17411400	Weak transcription	Aorta	Aorta
8	chr9:17368800-17411400	Weak transcription	Duodenum Smooth Muscle	Duodenum
9	chr9:17369000-17395000	Weak transcription	Stomach Smooth Muscle	stomach
10	chr9:17369400-17411200	Weak transcription	Fetal Muscle Trunk	muscle
11	chr9:17371400-17394800	Weak transcription	Cortex derived primary cultured neurospheres	brain
12	chr9:17377600-17403000	Weak transcription	Fetal Stomach	stomach
13	chr9:17379400-17404200	Weak transcription	Psoas Muscle	Psoas
14	chr9:17379600-17394800	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
15	chr9:17379800-17394600	Weak transcription	Monocytes-CD14+_RO01746	blood
16	chr9:17380600-17411000	Weak transcription	Left Ventricle	heart
17	chr9:17381000-17411200	Weak transcription	Fetal Muscle Leg	muscle
18	chr9:17381200-17411200	Weak transcription	Primary hematopoietic stem cells short term culture	blood
19	chr9:17381400-17397400	Weak transcription	Ovary	ovary
20	chr9:17381400-17422800	Weak transcription	Colon Smooth Muscle	Colon
21	chr9:17381800-17396000	Weak transcription	Liver	Liver
22	chr9:17382000-17394800	Weak transcription	Primary hematopoietic stem cells	blood
23	chr9:17385200-17396400	Weak transcription	Right Ventricle	heart
24	chr9:17385400-17411400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
25	chr9:17386800-17394600	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
26	chr9:17387000-17411200	Weak transcription	Dnd41	blood
27	chr9:17388200-17397200	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
28	chr9:17388200-17411400	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
29	chr9:17389000-17404200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr9:17389600-17396800	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
31	chr9:17390200-17394600	Weak transcription	Fetal Lung	lung
32	chr9:17391400-17397400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
33	chr9:17391600-17411200	Weak transcription	Breast Myoepithelial Primary Cells	Breast
34	chr9:17393000-17395000	Weak transcription	Fetal Heart	heart
35	chr9:17393400-17400600	Weak transcription	NH-A	brain
36	chr9:17393400-17411400	Weak transcription	Lung	lung
37	chr9:17393400-17433000	Weak transcription	Primary monocytes fromperipheralblood	blood
38	chr9:17393600-17412800	Weak transcription	Fetal Kidney	kidney
39	chr9:17393600-17413000	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
40	chr9:17393800-17394600	Enhancers	HUES48 Cell Line	embryonic stem cell
41	chr9:17393800-17394800	Weak transcription	NHDF-Ad	bronchial
42	chr9:17393800-17413000	Weak transcription	A549	lung
43	chr9:17394200-17396000	Enhancers	HUES6 Cell Line	embryonic stem cell
44	chr9:17394200-17396600	Enhancers	iPS-15b Cell Line	embryonic stem cell
45	chr9:17394200-17396800	Enhancers	HUES64 Cell Line	embryonic stem cell
46	chr9:17394600-17395200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
47	chr9:17394600-17395400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
48	chr9:17394600-17395400	Strong transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
49	chr9:17394600-17395600	Strong transcription	Fetal Lung	lung
50	chr9:17394600-17395600	Strong transcription	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links